GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF12 | hg19_v2_chr13_-_74708372_74708409 | -0.34 | 2.5e-07 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_89402148 Show fit | 23.04 |
ENST00000560601.1
|
aggrecan |
|
chrX_+_23682379 Show fit | 16.47 |
ENST00000379349.1
|
peroxiredoxin 4 |
|
chrX_+_49028265 Show fit | 11.17 |
ENST00000376322.3
ENST00000376327.5 |
proteolipid protein 2 (colonic epithelium-enriched) |
|
chr12_-_56120838 Show fit | 10.75 |
ENST00000548160.1
|
CD63 molecule |
|
chr1_+_155178481 Show fit | 10.68 |
ENST00000368376.3
|
metaxin 1 |
|
chr12_-_53012343 Show fit | 10.19 |
ENST00000305748.3
|
keratin 73 |
|
chr11_-_64013288 Show fit | 9.88 |
ENST00000542235.1
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
|
chr19_+_13051206 Show fit | 9.51 |
ENST00000586760.1
|
calreticulin |
|
chr15_+_64428529 Show fit | 9.39 |
ENST00000560861.1
|
sorting nexin 1 |
|
chr12_+_53848549 Show fit | 9.10 |
ENST00000439930.3
ENST00000548933.1 ENST00000562264.1 |
poly(rC) binding protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 33.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 29.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 23.4 | GO:0031424 | keratinization(GO:0031424) |
1.2 | 23.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 19.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.3 | 18.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.0 | 17.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 17.1 | GO:0048207 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.3 | 16.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
2.2 | 15.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 33.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 29.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 24.6 | GO:0031968 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.1 | 22.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 16.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 16.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.3 | 15.7 | GO:0045095 | keratin filament(GO:0045095) |
1.7 | 15.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.1 | 12.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.0 | 12.5 | GO:0005642 | annulate lamellae(GO:0005642) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 43.5 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 23.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.8 | 23.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 22.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.7 | 20.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.1 | 16.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 15.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 15.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
2.3 | 13.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.3 | 12.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 21.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 15.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 14.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 11.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 10.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 10.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 9.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 8.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 6.7 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 6.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 41.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 23.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.3 | 23.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 21.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 19.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 16.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 14.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 14.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 12.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 12.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |